• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO AVALUS AORTIC TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO AVALUS AORTIC TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 40027
Medical Device Problem Code Intravalvular regurgitation (4068)
Health Effect - Clinical Code Aortic Valve Insufficiency/ Regurgitation (4450)
Date of Event 09/30/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product analysis: the product has been returned and analysis is in progress medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Medtronic received information that during the implant of this 27mm aortic bioprosthetic valve, it was explanted and replaced with another manufacturers valve.The reason for the replacement was reported as aortic insufficiency (ai).It was stated that a high degree of central jet was noted and the leaflets of the valve were checked but the valve appeared to be in good shape.It was stated that no obvious cause of the central leak could be found.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
Product analysis: upon receipt at medtronic's quality laboratory, visual examination revealed the valve is discolored showing evidence of blood contact.The sewing ring is slightly inverted adjacent to leaflet 2.Small needle holes are observed along the sewing ring.Tears noted along the sewing ring on the outflow adjacent to leaflet 2 appears to have occurred while extracting the valve after implant.All leaflets are in the closed position with a gap at the point of coaptation and between the free margins of leaflets 2 and 3.All leaflets are slightly stiff but flexible which may be associated to blood contact and/or the decontamination solution.All leaflets are intact.All commissures appear intact.Updated data: h.6: coding medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVALUS AORTIC TISSUE VALVE
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX  22570
Manufacturer (Section G)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX   22570
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key20425882
Report Number9612164-2024-04636
Device Sequence Number8420059
Product Code LWR
UDI-Device Identifier00643169983212
UDI-Public00643169983212
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P170006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number40027
Device Catalogue Number40027
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/03/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/30/2024
Supplement Date Received by Manufacturer10/24/2024
Initial Report FDA Received Date10/11/2024
Supplement Report FDA Received Date11/22/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/04/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age83 YR
Patient SexMale
-
-